Views
4 years ago

91 - A Sánchez Toranzo - Abril 2015

  • Text
  • Scolari
  • Hansen
  • Eszopiclona
  • Zopiclona
  • Z
  • Hipnoticos
  • Toranzo
  • Nota
  • Psico
  • Zaleplon
  • Efecto
  • Aumento
  • Riesgo
  • Adversos
  • Dosis
  • Drogas
  • Insomnio
  • Efectos
  • Zolpidem
Grupo Z: hipnóticos no benzodiazepínicos

Dra. Adriana

Dra. Adriana Sánchez Toranzo, Dra. Federica Hansen, Farm. Scolari Mariano trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain. 2014.Sleep Jun 1;37(6):1053-60. 7. Greenblatt DJ, Zammit GK. Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications. Expert Opin Drug Metab Toxicol. 2012 Dec;8(12):1609-18. 8. Guerlais M1, Grall-Bronnec M, Feuillet F, Gérardin M, Jolliet P, Victorri-Vigneau C. Dependence on prescription benzodiazepines and Z-drugs among young to middle-aged patients in France. Subst Use Misuse. 2015 Feb;50(3):320-7 9. Gunja N.The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013 Jun;9(2):155- 62. 10. Jufe G. Cap.2: Ansiolíticos e hipnóticos, en Psicofarmacología Práctica. 2012. Ed.Polemos. p242-254. 11. Haji Seyed Javadi SA, Hajiali F, Nassiri-Asl M. Zolpidem dependency and withdrawal seizure: a case report study. Iran Red Crescent Med J. 2014. Nov 11; 16(11). 12. Huang RS, Lu YP Evaluation of Taiwan Consumer Drug Safety from National Taiwan Health Insurance Bureau. Taiwan Med J. 2013;56:8–10 (http://www.tma.tw/ ltk/ 102560102.pdf). 13. Huang WS, Tsai CH, Lin CC, Muo CH, Sung FC, Chang YJ, Kao CH. Relationship between zolpidem use and stroke risk: a Taiwanese population-based case-control study. J Clin Psychiatry. 2013 May; 74(5):e433-8. 14. Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;17;345:e8343. 15. Joya FL, Kripke DF, Loving RT, Dawson A, Kline LE. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med. 2009 Aug 15;5(4):377-83. 16. Kräuchi K, Cajochen C, Werth E, et al.Warm feet promote the rapid onset of sleep. Nature. 1999;401:36–7. 17. Krystal AD, McCall WV, Fava M, Joffe H, Soares CN, Huang H, Grinell T, Zummo J, Spalding W, Marshall R. Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. Prim Care Companion CNS Disord.2012; 14(4). 2012. 18. Leiderman EA,Mugnolo JF, Bruscoli N, Maíz J Consumo de psicofármacos en la población general de la ciudad de Buenos Aires. Vertex Rev. Arg. de Psiquiat. 2006; 17:85-91. 19. Lin FY, Chen PC, Liao CH, Hsieh YW, Sung FC. Retrospective population cohort study on hip fracture risk associated with zolpidem medication. Sleep. 2014 Apr 1;37(4):673-9. 20. MacFarlane J, Morin CM, Montplaisir J. Hypnotics in insomnia: the experience of zolpidem. Clin Ther.2014; Nov 1;36(11). 21. Mandrioli R, Mercolini L, Raggi MA. Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.Curr Drug Metab. 2010;11(9):815-29. 22. Mets MA, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, Verster JC. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep. 2011 Oct 1;34(10):1327-34. 23. Montenarh D, Hopf M, Maurer HH, Schmidt P, Ewald AH. Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach. Anal Bioanal Chem. 2014 Jan;406(3):803-18. 24. Mozaffarieh M, Flammer J. New insights in the pathogenesis and treatment of normal tension glaucoma. Curr Opin Pharmacol. 2013 Feb; 13(1):43-9. 25. Neuman MD, Silber JH, Magaziner JS, Passarella MA, Mehta S, Werner RM. Survival and functional outcomes after hip fracture among nursing home residents. JAMA Intern Med. 2014 Aug; 174(8):1273-80. 26. Pacia JL, García Alfarob M, Redondo FJ, Fernández MI. Prescripción inadecuada en pacientes polimedicados mayores de 64 anosen atención primaria. Aten Primaria. 2015;47(1):38-47. 27. Pergolizzi, Jr. JV, Taylor, Jr. R, Raffa RB, Nalamachu S, Chopra M. Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness. Sleep Disord. 2014; 2014: 527109. 28. Piotrowski P, Bocian S, Śliwka K, Buszewski B. Simultaneous analysis of zolpidem and its metabolite in whole blood and oral fluid samples by SPE-LC/MS for clinical and forensic purposes. Adv Med Sci. 2015 Mar;60(1):167-72. 29. Rosenberg R, Caron J, Roth T, Amato D. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. Sleep Med. 2005 Jan;6(1):15- 22. 30. Sharma A, Sayeed N, Khees CR, Akhtar S. High dose zolpidem induced fetal neural tube defects. Curr Drug Saf. 2011 Apr;6(2):128-9. 31. Singh H, Thangaraju P, Natt NK. Sleepwalking a rarest side effect of zolpidem. Indian J Psychol Med. 2015 Jan-Mar;37(1):105-6. 32. Stone BM, Turner C, Mills SL, Paty I, Patat A, Darwish M, Danjou P. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. Br J Clin Pharmacol. 2002 Feb;53(2):196-202. 33. Stranks EK, Crowe SF. The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and metaanalysis. J Clin Exp Neuropsychol. 2014;36(7):691-700. 34. Wang LH, Lin HC, Lin CC, Chen YH, Lin HC. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther. 2010 Sep;88(3):369-74. 35. Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ. 2014 Mar 19;348:g1996. doi: 10.1136/bmj.g1996. 36. Wikner BN, Källén B. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol. 2011 Jun;31(3):356-9. 37. Yen CF, Yen CN, Ko CH, Hwang TJ, Chen CS, Chen TT, Su PW, Chen ST, Lin JJ. Correlates of dependence and beliefs about the use of hypnotics among zolpidem and zopiclone users. Subst Use Misuse. 2015 Feb;50(3):350- 7. 38. Yi-Hao Ho, Yue-Cune Chang, Wei-Cheng Huang, Hsin-Yi Chen, Che-Chen Lin, Fung- Chang Sung. Association Between Zolpidem Use and Glaucoma Risk: A Taiwanese Population-Based Case-Control Study J Epidemiol. 2015; 25(1): 15–19. 30 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015